| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -40 @ USD 120.1 | USD -4,804 | The ETF sold 40 shares of DVA on 2025-11-26. The shares were previously bought for an average price of USD 144.3. The DaVita HealthCare Partners Inc shares were sold for -16.8% lower than average price of previous purchases. This resulted in an overall loss of USD 968 The average price that the ETF previously sold DVA share for is USD 142.549 which is higher than the selling price of USD 120.1 on 2025-11-26. |
| HSIC - Henry Schein Inc | SELL | -116 @ USD 75.25 | USD -8,729 | The ETF sold 116 shares of HSIC on 2025-11-26. The shares were previously bought for an average price of USD 71.0698. The Henry Schein Inc shares were sold for 5.9% higher than average price of previous purchases. This sale made a profit of USD 485 The average price that the ETF previously sold HSIC share for is USD 69.8061 so the ETF has sold 116 shares on 2025-11-26 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -60 @ USD 148.33 | USD -8,900 | The ETF sold 60 shares of MOH on 2025-11-26. The shares were previously bought for an average price of USD 257.108. The MOH shares were sold for -42.3% lower than average price of previous purchases. This resulted in an overall loss of USD 6,527 The average price that the ETF previously sold MOH share for is USD 291.214 which is higher than the selling price of USD 148.33 on 2025-11-26. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 148.33 | USD -8,900 | The ETF sold 60 shares of MOH on 2025-11-26. The shares were previously bought for an average price of USD 257.108. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -42.3% lower than average price of previous purchases. This resulted in an overall loss of USD 6,527 The average price that the ETF previously sold MOH share for is USD 291.214 which is higher than the selling price of USD 148.33 on 2025-11-26. |
| MRNA - Moderna Inc | SELL | -384 @ USD 25.01 | USD -9,604 | The ETF sold 384 shares of MRNA on 2025-11-26. The shares were previously bought for an average price of USD 31.3604. The Moderna Inc shares were sold for -20.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,439 The average price that the ETF previously sold MRNA share for is USD 37.0958 which is higher than the selling price of USD 25.01 on 2025-11-26. |
| CRL - Creightons Plc | SELL | -54 @ USD 178.94 | USD -9,663 | The ETF sold 54 shares of CRL on 2025-11-26. The shares were previously bought for an average price of USD 167.678. The Creightons Plc shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of USD 608 The average price that the ETF previously sold CRL share for is USD 173.621 so the ETF has sold 54 shares on 2025-11-26 at a higher price than the previous selling average. |
| BAX - Baxter International Inc | SELL | -574 @ USD 18.91 | USD -10,854 | The ETF sold 574 shares of BAX on 2025-11-26. The shares were previously bought for an average price of USD 28.7492. The Baxter International Inc shares were sold for -34.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,648 The average price that the ETF previously sold BAX share for is USD 31.2694 which is higher than the selling price of USD 18.91 on 2025-11-26. |
| ALGN - Align Technology Inc | SELL | -74 @ USD 147.23 | USD -10,895 | The ETF sold 74 shares of ALGN on 2025-11-26. The shares were previously bought for an average price of USD 172.15. The Align Technology Inc shares were sold for -14.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,844 The average price that the ETF previously sold ALGN share for is USD 199.85 which is higher than the selling price of USD 147.23 on 2025-11-26. |
| TECH - Bio-Techne Corp | SELL | -174 @ USD 64.63 | USD -11,246 | The ETF sold 174 shares of TECH on 2025-11-26. The shares were previously bought for an average price of USD 62.313. The Bio-Techne Corp shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 403 The average price that the ETF previously sold TECH share for is USD 65.0151 which is higher than the selling price of USD 64.63 on 2025-11-26. |
| RVTY - Revvity Inc. | SELL | -130 @ USD 104.66 | USD -13,606 | The ETF sold 130 shares of RVTY on 2025-11-26. The shares were previously bought for an average price of USD 105.176. The Revvity Inc. shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 67 The average price that the ETF previously sold RVTY share for is USD 106.643 which is higher than the selling price of USD 104.66 on 2025-11-26. |
| VTRS - Viatris Inc | SELL | -1,290 @ USD 10.64 | USD -13,726 | The ETF sold 1290 shares of VTRS on 2025-11-26. The shares were previously bought for an average price of USD 10.2419. The Viatris Inc shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 514 The average price that the ETF previously sold VTRS share for is USD 10.9708 which is higher than the selling price of USD 10.64 on 2025-11-26. |
| SOLV - Solventum Corp. | SELL | -164 @ USD 85.27 | USD -13,984 | The ETF sold 164 shares of SOLV on 2025-11-26. The shares were previously bought for an average price of USD 73.7528. The Solventum Corp. shares were sold for 15.6% higher than average price of previous purchases. This sale made a profit of USD 1,889 The average price that the ETF previously sold SOLV share for is USD 72.0398 so the ETF has sold 164 shares on 2025-11-26 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 244.18 | USD -15,139 | The ETF sold 62 shares of UHS on 2025-11-26. The shares were previously bought for an average price of USD 195.981. The Universal Health Services Inc shares were sold for 24.6% higher than average price of previous purchases. This sale made a profit of USD 2,988 The average price that the ETF previously sold UHS share for is USD 193.889 so the ETF has sold 62 shares on 2025-11-26 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -222 @ USD 77.94 | USD -17,303 | The ETF sold 222 shares of COO on 2025-11-26. The shares were previously bought for an average price of USD 81.9793. The The Cooper Companies, Inc. Common Stock shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of USD 897 The average price that the ETF previously sold COO share for is USD 89.0113 which is higher than the selling price of USD 77.94 on 2025-11-26. |
| HOLX - Hologic Inc | SELL | -246 @ USD 74.8 | USD -18,401 | The ETF sold 246 shares of HOLX on 2025-11-26. The shares were previously bought for an average price of USD 67.9792. The Hologic Inc shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 1,678 The average price that the ETF previously sold HOLX share for is USD 70.638 so the ETF has sold 246 shares on 2025-11-26 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -184 @ USD 105.65 | USD -19,440 | The ETF sold 184 shares of INCY on 2025-11-26. The shares were previously bought for an average price of USD 77.7166. The Incyte Corporation shares were sold for 35.9% higher than average price of previous purchases. This sale made a profit of USD 5,140 The average price that the ETF previously sold INCY share for is USD 74.3458 so the ETF has sold 184 shares on 2025-11-26 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -520 @ USD 39.46 | USD -20,519 | The ETF sold 520 shares of CNC on 2025-11-26. The shares were previously bought for an average price of USD 51.2355. The Concurrent Technologies Plc shares were sold for -23.0% lower than average price of previous purchases. This resulted in an overall loss of USD 6,123 The average price that the ETF previously sold CNC share for is USD 51.0845 which is higher than the selling price of USD 39.46 on 2025-11-26. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -220 @ USD 97.55 | USD -21,461 | The ETF sold 220 shares of ZBH on 2025-11-26. The shares were previously bought for an average price of USD 102.297. The Zimmer Biomet Holdings Inc shares were sold for -4.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,044 The average price that the ETF previously sold ZBH share for is USD 103.87 which is higher than the selling price of USD 97.55 on 2025-11-26. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 277.14 | USD -21,617 | The ETF sold 78 shares of WST on 2025-11-26. The shares were previously bought for an average price of USD 260.285. The West Pharmaceutical Services Inc shares were sold for 6.5% higher than average price of previous purchases. This sale made a profit of USD 1,315 The average price that the ETF previously sold WST share for is USD 278.612 which is higher than the selling price of USD 277.14 on 2025-11-26. |
| DGX - Quest Diagnostics Incorporated | SELL | -122 @ USD 189.69 | USD -23,142 | The ETF sold 122 shares of DGX on 2025-11-26. The shares were previously bought for an average price of USD 173.069. The Quest Diagnostics Incorporated shares were sold for 9.6% higher than average price of previous purchases. This sale made a profit of USD 2,028 The average price that the ETF previously sold DGX share for is USD 166.983 so the ETF has sold 122 shares on 2025-11-26 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -92 @ USD 268.27 | USD -24,681 | The ETF sold 92 shares of LH on 2025-11-26. The shares were previously bought for an average price of USD 254.152. The Laboratory Corporation of America Holdings shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of USD 1,299 The average price that the ETF previously sold LH share for is USD 244.633 so the ETF has sold 92 shares on 2025-11-26 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -78 @ USD 326.8 | USD -25,490 | The ETF sold 78 shares of PODD on 2025-11-26. The shares were previously bought for an average price of USD 290.832. The Insulet Corporation shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 2,806 The average price that the ETF previously sold PODD share for is USD 278.5 so the ETF has sold 78 shares on 2025-11-26 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -66 @ USD 407.14 | USD -26,871 | The ETF sold 66 shares of WAT on 2025-11-26. The shares were previously bought for an average price of USD 358.506. The Waters Corporation shares were sold for 13.6% higher than average price of previous purchases. This sale made a profit of USD 3,210 The average price that the ETF previously sold WAT share for is USD 362.193 so the ETF has sold 66 shares on 2025-11-26 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -66 @ USD 407.14 | USD -26,871 | The ETF sold 66 shares of WAT on 2025-11-26. The shares were previously bought for an average price of USD 358.506. The MULETFWATIMETFP shares were sold for 13.6% higher than average price of previous purchases. This sale made a profit of USD 3,210 The average price that the ETF previously sold WAT share for is USD 362.193 so the ETF has sold 66 shares on 2025-11-26 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -436 @ USD 62.53 | USD -27,263 | The ETF sold 436 shares of DXCM on 2025-11-26. The shares were previously bought for an average price of USD 73.8055. The DexCom Inc shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,916 The average price that the ETF previously sold DXCM share for is USD 76.276 which is higher than the selling price of USD 62.53 on 2025-11-26. |
| STE - STERIS plc | SELL | -108 @ USD 266.85 | USD -28,820 | The ETF sold 108 shares of STE on 2025-11-26. The shares were previously bought for an average price of USD 231.89. The STERIS plc shares were sold for 15.1% higher than average price of previous purchases. This sale made a profit of USD 3,776 The average price that the ETF previously sold STE share for is USD 225.44 so the ETF has sold 108 shares on 2025-11-26 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -162 @ USD 181.94 | USD -29,474 | The ETF sold 162 shares of BIIB on 2025-11-26. The shares were previously bought for an average price of USD 145.309. The Biogen Inc shares were sold for 25.2% higher than average price of previous purchases. This sale made a profit of USD 5,934 The average price that the ETF previously sold BIIB share for is USD 151.639 so the ETF has sold 162 shares on 2025-11-26 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -132 @ USD 245.99 | USD -32,471 | The ETF sold 132 shares of HUM on 2025-11-26. The shares were previously bought for an average price of USD 263.126. The Hummingbird Resources PLC shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,262 The average price that the ETF previously sold HUM share for is USD 270.162 which is higher than the selling price of USD 245.99 on 2025-11-26. |
| HUM - Humana Inc | SELL | -132 @ USD 245.99 | USD -32,471 | The ETF sold 132 shares of HUM on 2025-11-26. The shares were previously bought for an average price of USD 263.126. The Humana Inc shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,262 The average price that the ETF previously sold HUM share for is USD 270.162 which is higher than the selling price of USD 245.99 on 2025-11-26. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1486.55 | USD -32,704 | The ETF sold 22 shares of MTD on 2025-11-26. The shares were previously bought for an average price of USD 1280.98. The Mettler-Toledo International Inc shares were sold for 16.0% higher than average price of previous purchases. This sale made a profit of USD 4,523 The average price that the ETF previously sold MTD share for is USD 1243.43 so the ETF has sold 22 shares on 2025-11-26 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1486.55 | USD -32,704 | The ETF sold 22 shares of MTD on 2025-11-26. The shares were previously bought for an average price of USD 1280.98. The AMUNDI EUR GOV 710 shares were sold for 16.0% higher than average price of previous purchases. This sale made a profit of USD 4,523 The average price that the ETF previously sold MTD share for is USD 1243.43 so the ETF has sold 22 shares on 2025-11-26 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -504 @ USD 80.63 | USD -40,638 | The ETF sold 504 shares of GEHC on 2025-11-26. The shares were previously bought for an average price of USD 79.887. The GE HealthCare Technologies Inc. shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 374 The average price that the ETF previously sold GEHC share for is USD 79.1958 so the ETF has sold 504 shares on 2025-11-26 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -162 @ USD 255.04 | USD -41,316 | The ETF sold 162 shares of RMD on 2025-11-26. The shares were previously bought for an average price of USD 246.326. The ResMed Inc shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 1,412 The average price that the ETF previously sold RMD share for is USD 246.869 so the ETF has sold 162 shares on 2025-11-26 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -186 @ USD 231.8 | USD -43,115 | The ETF sold 186 shares of IQV on 2025-11-26. The shares were previously bought for an average price of USD 192.778. The IQVIA Holdings Inc shares were sold for 20.2% higher than average price of previous purchases. This sale made a profit of USD 7,258 The average price that the ETF previously sold IQV share for is USD 188.642 so the ETF has sold 186 shares on 2025-11-26 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -314 @ USD 154.37 | USD -48,472 | The ETF sold 314 shares of A on 2025-11-26. The shares were previously bought for an average price of USD 132.346. The Agilent Technologies Inc shares were sold for 16.6% higher than average price of previous purchases. This sale made a profit of USD 6,916 The average price that the ETF previously sold A share for is USD 130.079 so the ETF has sold 314 shares on 2025-11-26 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -262 @ USD 213.14 | USD -55,843 | The ETF sold 262 shares of CAH on 2025-11-26. The shares were previously bought for an average price of USD 146.753. The Cardinal Health Inc shares were sold for 45.2% higher than average price of previous purchases. This sale made a profit of USD 17,393 The average price that the ETF previously sold CAH share for is USD 138.64 so the ETF has sold 262 shares on 2025-11-26 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -648 @ USD 86.75 | USD -56,214 | The ETF sold 648 shares of EW on 2025-11-26. The shares were previously bought for an average price of USD 74.1431. The Edwards Lifesciences Corp shares were sold for 17.0% higher than average price of previous purchases. This sale made a profit of USD 8,169 The average price that the ETF previously sold EW share for is USD 72.2459 so the ETF has sold 648 shares on 2025-11-26 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -314 @ USD 193.9 | USD -60,885 | The ETF sold 314 shares of BDX on 2025-11-26. The shares were previously bought for an average price of USD 208.486. The Becton Dickinson and Company shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 4,580 The average price that the ETF previously sold BDX share for is USD 207.348 which is higher than the selling price of USD 193.9 on 2025-11-26. |
| ZTS - Zoetis Inc | SELL | -490 @ USD 127.69 | USD -62,568 | The ETF sold 490 shares of ZTS on 2025-11-26. The shares were previously bought for an average price of USD 155.805. The Zoetis Inc shares were sold for -18.0% lower than average price of previous purchases. This resulted in an overall loss of USD 13,776 The average price that the ETF previously sold ZTS share for is USD 166.782 which is higher than the selling price of USD 127.69 on 2025-11-26. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 755.96 | USD -66,524 | The ETF sold 88 shares of IDXX on 2025-11-26. The shares were previously bought for an average price of USD 526.407. The IDEXX Laboratories Inc shares were sold for 43.6% higher than average price of previous purchases. This sale made a profit of USD 20,201 The average price that the ETF previously sold IDXX share for is USD 479.458 so the ETF has sold 88 shares on 2025-11-26 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -212 @ USD 368.53 | USD -78,128 | The ETF sold 212 shares of COR on 2025-11-26. The shares were previously bought for an average price of USD 296.301. The Cencora Inc. shares were sold for 24.4% higher than average price of previous purchases. This sale made a profit of USD 15,313 The average price that the ETF previously sold COR share for is USD 269.519 so the ETF has sold 212 shares on 2025-11-26 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -294 @ USD 278.35 | USD -81,835 | The ETF sold 294 shares of CI on 2025-11-26. The shares were previously bought for an average price of USD 302.805. The Cigna Corp shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 7,190 The average price that the ETF previously sold CI share for is USD 315.61 which is higher than the selling price of USD 278.35 on 2025-11-26. |
| ELV - Elevance Health Inc | SELL | -248 @ USD 338.52 | USD -83,953 | The ETF sold 248 shares of ELV on 2025-11-26. The shares were previously bought for an average price of USD 376.939. The Elevance Health Inc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 9,528 The average price that the ETF previously sold ELV share for is USD 391.167 which is higher than the selling price of USD 338.52 on 2025-11-26. |
| ELV - Elevance Health Inc | SELL | -248 @ USD 338.52 | USD -83,953 | The ETF sold 248 shares of ELV on 2025-11-26. The shares were previously bought for an average price of USD 376.939. The Elevance Health Inc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 9,528 The average price that the ETF previously sold ELV share for is USD 391.167 which is higher than the selling price of USD 338.52 on 2025-11-26. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -112 @ USD 784.61 | USD -87,876 | The ETF sold 112 shares of REGN on 2025-11-26. The shares were previously bought for an average price of USD 660.311. The Regeneron Pharmaceuticals Inc shares were sold for 18.8% higher than average price of previous purchases. This sale made a profit of USD 13,921 The average price that the ETF previously sold REGN share for is USD 682.857 so the ETF has sold 112 shares on 2025-11-26 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -180 @ USD 514.76 | USD -92,657 | The ETF sold 180 shares of HCA on 2025-11-26. The shares were previously bought for an average price of USD 378.339. The HCA Holdings Inc shares were sold for 36.1% higher than average price of previous purchases. This sale made a profit of USD 24,556 The average price that the ETF previously sold HCA share for is USD 367.055 so the ETF has sold 180 shares on 2025-11-26 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,240 @ USD 49.25 | USD -110,320 | The ETF sold 2240 shares of BMY on 2025-11-26. The shares were previously bought for an average price of USD 52.1364. The Bloomsbury Publishing Plc shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 6,466 The average price that the ETF previously sold BMY share for is USD 53.2179 which is higher than the selling price of USD 49.25 on 2025-11-26. |
| CVS - CVS Health Corp | SELL | -1,396 @ USD 79.86 | USD -111,485 | The ETF sold 1396 shares of CVS on 2025-11-26. The shares were previously bought for an average price of USD 68.5778. The CVS Health Corp shares were sold for 16.5% higher than average price of previous purchases. This sale made a profit of USD 15,750 The average price that the ETF previously sold CVS share for is USD 61.7367 so the ETF has sold 1396 shares on 2025-11-26 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -136 @ USD 883.71 | USD -120,185 | The ETF sold 136 shares of MCK on 2025-11-26. The shares were previously bought for an average price of USD 694.754. The McKesson Corporation shares were sold for 27.2% higher than average price of previous purchases. This sale made a profit of USD 25,698 The average price that the ETF previously sold MCK share for is USD 660.52 so the ETF has sold 136 shares on 2025-11-26 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -282 @ USD 432.17 | USD -121,872 | The ETF sold 282 shares of VRTX on 2025-11-26. The shares were previously bought for an average price of USD 447.335. The Vertex Pharmaceuticals Inc shares were sold for -3.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,277 The average price that the ETF previously sold VRTX share for is USD 467.915 which is higher than the selling price of USD 432.17 on 2025-11-26. |
| SYK - Stryker Corporation | SELL | -378 @ USD 372.29 | USD -140,726 | The ETF sold 378 shares of SYK on 2025-11-26. The shares were previously bought for an average price of USD 375.537. The Stryker Corporation shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,227 The average price that the ETF previously sold SYK share for is USD 380.024 which is higher than the selling price of USD 372.29 on 2025-11-26. |
| MDT - Medtronic PLC | SELL | -1,408 @ USD 105.02 | USD -147,868 | The ETF sold 1408 shares of MDT on 2025-11-26. The shares were previously bought for an average price of USD 90.7647. The Medtronic PLC shares were sold for 15.7% higher than average price of previous purchases. This sale made a profit of USD 20,071 The average price that the ETF previously sold MDT share for is USD 87.4739 so the ETF has sold 1408 shares on 2025-11-26 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -698 @ USD 228.46 | USD -159,465 | The ETF sold 698 shares of DHR on 2025-11-26. The shares were previously bought for an average price of USD 213.901. The Danaher Corporation shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 10,162 The average price that the ETF previously sold DHR share for is USD 222.162 so the ETF has sold 698 shares on 2025-11-26 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -698 @ USD 228.46 | USD -159,465 | The ETF sold 698 shares of DHR on 2025-11-26. The shares were previously bought for an average price of USD 213.901. The Danaher Corporation shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 10,162 The average price that the ETF previously sold DHR share for is USD 222.162 so the ETF has sold 698 shares on 2025-11-26 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -6,260 @ USD 25.71 | USD -160,945 | The ETF sold 6260 shares of PFE on 2025-11-26. The shares were previously bought for an average price of USD 25.3496. The Pfizer Inc shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of USD 2,256 The average price that the ETF previously sold PFE share for is USD 25.3676 so the ETF has sold 6260 shares on 2025-11-26 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -1,630 @ USD 100.96 | USD -164,565 | The ETF sold 1630 shares of BSX on 2025-11-26. The shares were previously bought for an average price of USD 99.3574. The Boston Scientific Corporation shares were sold for 1.6% higher than average price of previous purchases. This sale made a profit of USD 2,612 The average price that the ETF previously sold BSX share for is USD 94.7873 so the ETF has sold 1630 shares on 2025-11-26 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,630 @ USD 100.96 | USD -164,565 | The ETF sold 1630 shares of BSX on 2025-11-26. The shares were previously bought for an average price of USD 99.3574. The MULSTRXSSXIMETFP shares were sold for 1.6% higher than average price of previous purchases. This sale made a profit of USD 2,612 The average price that the ETF previously sold BSX share for is USD 94.7873 so the ETF has sold 1630 shares on 2025-11-26 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -1,366 @ USD 127.51 | USD -174,179 | The ETF sold 1366 shares of GILD on 2025-11-26. The shares were previously bought for an average price of USD 108.606. The Guild Esports Plc shares were sold for 17.4% higher than average price of previous purchases. This sale made a profit of USD 25,823 The average price that the ETF previously sold GILD share for is USD 100.9 so the ETF has sold 1366 shares on 2025-11-26 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -592 @ USD 344.57 | USD -203,985 | The ETF sold 592 shares of AMGN on 2025-11-26. The shares were previously bought for an average price of USD 301.259. The Amgen Inc shares were sold for 14.4% higher than average price of previous purchases. This sale made a profit of USD 25,640 The average price that the ETF previously sold AMGN share for is USD 294.767 so the ETF has sold 592 shares on 2025-11-26 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -394 @ USD 574.23 | USD -226,247 | The ETF sold 394 shares of ISRG on 2025-11-26. The shares were previously bought for an average price of USD 522.222. The Intuitive Surgical Inc shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 20,491 The average price that the ETF previously sold ISRG share for is USD 529.49 so the ETF has sold 394 shares on 2025-11-26 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -414 @ USD 593.25 | USD -245,606 | The ETF sold 414 shares of TMO on 2025-11-26. The shares were previously bought for an average price of USD 520.031. The Time Out Group plc shares were sold for 14.1% higher than average price of previous purchases. This sale made a profit of USD 30,313 The average price that the ETF previously sold TMO share for is USD 496.936 so the ETF has sold 414 shares on 2025-11-26 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -1,914 @ USD 128.54 | USD -246,026 | The ETF sold 1914 shares of ABT on 2025-11-26. The shares were previously bought for an average price of USD 128.31. The Abbott Laboratories shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of USD 440 The average price that the ETF previously sold ABT share for is USD 123.244 so the ETF has sold 1914 shares on 2025-11-26 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -2,746 @ USD 104.63 | USD -287,314 | The ETF sold 2746 shares of MRK on 2025-11-26. The shares were previously bought for an average price of USD 89.4762. The Marks Electrical Group PLC shares were sold for 16.9% higher than average price of previous purchases. This sale made a profit of USD 41,612 The average price that the ETF previously sold MRK share for is USD 92.9052 so the ETF has sold 2746 shares on 2025-11-26 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -2,746 @ USD 104.63 | USD -287,314 | The ETF sold 2746 shares of MRK on 2025-11-26. The shares were previously bought for an average price of USD 89.4762. The Merck & Company Inc shares were sold for 16.9% higher than average price of previous purchases. This sale made a profit of USD 41,612 The average price that the ETF previously sold MRK share for is USD 92.9052 so the ETF has sold 2746 shares on 2025-11-26 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -994 @ USD 329.71 | USD -327,732 | The ETF sold 994 shares of UNH on 2025-11-26. The shares were previously bought for an average price of USD 438.604. The UnitedHealth Group Incorporated shares were sold for -24.8% lower than average price of previous purchases. This resulted in an overall loss of USD 108,241 The average price that the ETF previously sold UNH share for is USD 479.031 which is higher than the selling price of USD 329.71 on 2025-11-26. |
| ABBV - AbbVie Inc | SELL | -1,940 @ USD 227.66 | USD -441,660 | The ETF sold 1940 shares of ABBV on 2025-11-26. The shares were previously bought for an average price of USD 203.41. The AbbVie Inc shares were sold for 11.9% higher than average price of previous purchases. This sale made a profit of USD 47,045 The average price that the ETF previously sold ABBV share for is USD 190.833 so the ETF has sold 1940 shares on 2025-11-26 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -2,646 @ USD 207.56 | USD -549,204 | The ETF sold 2646 shares of JNJ on 2025-11-26. The shares were previously bought for an average price of USD 168.326. The Johnson & Johnson shares were sold for 23.3% higher than average price of previous purchases. This sale made a profit of USD 103,813 The average price that the ETF previously sold JNJ share for is USD 158.134 so the ETF has sold 2646 shares on 2025-11-26 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -874 @ USD 1104.34 | USD -965,193 | The ETF sold 874 shares of LLY on 2025-11-26. The shares were previously bought for an average price of USD 836.637. The Eli Lilly and Company shares were sold for 32.0% higher than average price of previous purchases. This sale made a profit of USD 233,972 The average price that the ETF previously sold LLY share for is USD 801.17 so the ETF has sold 874 shares on 2025-11-26 at a higher price than the previous selling average. |